HIV :: Coordination in HIV prevention research needed
HIV prevention research was responsible for the recent revelation that male circumcision can play an important role in protecting men from infection with the deadly virus.
HIV prevention research was responsible for the recent revelation that male circumcision can play an important role in protecting men from infection with the deadly virus.
A new meta-analysis examining the effect of antioxidant supplements on all-cause mortality published in the Feb. 28, 2007 issue of the Journal of the American Medical Association (JAMA) misuses meta-analysis methods to create generalized conclusions that may inappropriately confuse and alarm consumers who can benefit from supplementing with antioxidants, said the Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement industry.
Persons affected by glaucoma are over three times more likely to have been involved in falls and motor vehicle accidents than persons of the same age without the condition, say researchers from Dalhousie University in Canada.
In clinical studies for the lead indication of multiple sclerosis (MS), Revimmune improves function in most patients and stops progression in over 90 percent of cases refractory to standard therapies.
GlaxoSmithKline (GSK) announced the presentation of new data on fluticasone furoate nasal spray (FFNS), an enhanced affinity intranasal corticosteroid (INS) currently in development for use in the treatment of allergic rhinitis.
The Food and Drug Administration (FDA) announced the approval of two formulations of Cerenia (maropitant citrate), a new class of drug that is effective against certain causes of vomiting in dogs.
Australian scientists believe they may be able to use a common cold-producingvirus to successfully treat breast cancer patients, in a way that is much lessdebilitating than chemotherapy.
A new study examined the relationship between physical appearance concerns and psychological distress (depression and anxiety) in patients with RA and lupus.
The Food and Drug Administration (FDA) today approved Humira (adalimumab) to treat adult patients with moderately to severely active Crohn’s disease, a chronic inflammatory disease of the intestines, which affects an estimated one million Americans.
Multiple sclerosis, a neurodegenerative autoimmune disease in which the fatty covering of nerves becomes increasingly damaged, can manifest itself in many ways.